Hildur Helgadóttir

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated <i>BRAF</i>-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial

Paolo A. Ascierto, Mario Mandalà, Pier Francesco Ferrucci et al. · Journal of Clinical Oncology · 2022 · 208 citations

The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma

Lars Ny, Henrik Jespersen, Joakim Karlsson et al. · Nature Communications · 2021 · 170 citations · Full text

Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients

Håkon Håkonarson, Unnur Steina Björnsdóttir, Eva Halapi et al. · Proceedings of the National Academy of Sciences · 2005 · 161 citations · Full text

TGF-β signaling–deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro

Jonas Larsson, Ulrika Blank, Hildur Helgadóttir et al. · Blood · 2003 · 148 citations · Full text

High risk of tobacco-related cancers in <i>CDKN2A</i> mutation-positive melanoma families

Hildur Helgadóttir, Veronica Höiom, Göran Jönsson et al. · Journal of Medical Genetics · 2014 · 103 citations · Full text